Volume 10, Number 2—February 2004
THEME ISSUE
2004 SARS Edition
SARS Origins
Susceptibility of Pigs and Chickens to SARS Coronavirus
Hana M. Weingartl*
, John Copps*, Michael A. Drebot*, Peter Marszal*, Greg Smith*, Jason Gren*, Maya Andonova*, John Pasick*, Paul Kitching*, and Markus Czub*
, John Copps*, Michael A. Drebot*, Peter Marszal*, Greg Smith*, Jason Gren*, Maya Andonova*, John Pasick*, Paul Kitching*, and Markus Czub*
Table 4
Overview of virus neutralization titers for pig preimmune and immune sera against SARS-CoV and TGEVa
| Pig no. | Pre-inoculation bleed serum antibody titer |
Final bleed serum antibody titer |
||||
|---|---|---|---|---|---|---|
| VNT TGEV | VNT SARS | PRNT TGEV | VNT TGEV | VNT SARS | PRNT SARS | |
| 7 |
0 |
0 |
0 |
0 |
20 |
10 |
| 8 |
20+ |
0 |
0 |
20 |
320 |
160 |
| 9 |
10 |
0 |
0 |
0 |
160 |
80 |
| 10 |
20 |
0 |
0 |
10 |
80+ |
80 |
| 11 |
10 |
0 |
0 |
0 |
40 |
40 |
| 12 | 20 | 0 | 0 | 0 | 80 | 80 |
aDetermined by microtiter virus neutralization test (VNT) and plaque reduction neutralization test (PRNT). SARS-CoV, severe acute respiratory syndrome-coronavirus; TGEV, transmissible gastroenteritis virus.
Page created: January 26, 2011
Page updated: January 26, 2011
Page reviewed: January 26, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.